Literature DB >> 1265672

Reversibility of severe hepatic damage caused by jejunoileal bypass after re-establishment of normal intestinal continuity.

M T Soyer, R Ceballos, J S Aldrete.   

Abstract

This case report attempts to document the reversibility of advanced hepatic anatomical and clinical alterations compatible with advanced hepatic cirrhosis that occasionally develop in patients with jejunoileal bypass performed for morbid obesity. The advanced stage of this complication can be fatal unless the intestinal continuity is returned to normal.

Entities:  

Mesh:

Year:  1976        PMID: 1265672

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  9 in total

1.  Reasons and operative outcomes after reversal of gastric bypass and jejunoileal bypass.

Authors:  Elias Chousleb; Sheetal Patel; Samuel Szomstein; Raul Rosenthal
Journal:  Obes Surg       Date:  2012-10       Impact factor: 4.129

Review 2.  Liver fibrosis.

Authors:  Ramón Bataller; David A Brenner
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

Review 3.  Hepatic inflammation and progressive liver fibrosis in chronic liver disease.

Authors:  Albert J Czaja
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

4.  Hepatoprotective effect of juglone on dimethylnitrosamine-induced liver fibrosis and its effect on hepatic antioxidant defence and the expression levels of α-SMA and collagen III.

Authors:  De-Jiang Zhou; Dong Mu; Ming-De Jiang; Shu-Mei Zheng; Yong Zhang; Sheng He; Min Weng; Wei-Zheng Zeng
Journal:  Mol Med Rep       Date:  2015-06-24       Impact factor: 2.952

5.  Protective effects of Ampelopsis brevipedunculata against in vitro hepatic stellate cells system and thioacetamide-induced liver fibrosis rat model.

Authors:  Mun Jeong Yum; Sushruta Koppula; Jin Seoub Kim; Gwang Mo Shin; Yun Jin Chae; Tony Yoon; Chi Su Chun; Jae Dong Lee; MinDong Song
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

6.  Anti-hepatofibrosis effect of Allium senescens in activated hepatic stellate cells and thioacetamide-induced fibrosis rat model.

Authors:  Gwang-Mo Shin; Sushruta Koppula; Yun-Jin Chae; Hyun-Su Kim; Jae-Dong Lee; Myong-Ki Kim; MinDong Song
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

7.  Circular RNA circFBXW4 suppresses hepatic fibrosis via targeting the miR-18b-3p/FBXW7 axis.

Authors:  Xin Chen; Hai-Di Li; Fang-Tian Bu; Xiao-Feng Li; Yu Chen; Sai Zhu; Jia-Nan Wang; Si-Yu Chen; Ying-Yin Sun; Xue-Yin Pan; Na-Na Yin; Jie-Jie Xu; Cheng Huang; Jun Li
Journal:  Theranostics       Date:  2020-03-26       Impact factor: 11.556

Review 8.  The Role of Sinusoidal Endothelial Cells in the Axis of Inflammation and Cancer Within the Liver.

Authors:  Alex L Wilkinson; Maria Qurashi; Shishir Shetty
Journal:  Front Physiol       Date:  2020-08-28       Impact factor: 4.566

9.  Proteomic Analysis of Human Serum for Patients at Different Pathological Stages of Hepatic Fibrosis.

Authors:  Kang Zhao; Jucun Huang; Hongmei Xia; Jianjun Zhang; Liming Liu
Journal:  Biomed Res Int       Date:  2021-11-28       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.